Publication|Articles|August 19, 2024
- Applied Clinical Trials-08-01-2024
- Volume 33
- Issue 8
Applied Clinical Trials July/August 2024 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials July/August 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
What's Next for DCTs?almost 2 years ago
Streamlining Clinical Trials with eSource: Insights from MSKalmost 2 years ago
Decentralized Clinical Trials: Bust or Breakthrough?almost 2 years ago
The Evolution of CRAACO: Gains and Lessons Learnedalmost 2 years ago
'Fit-for-Purpose' Considerations for Remote Trialsalmost 2 years ago
Rethinking Training: The Benefits of Embracing ‘Desirable Difficulties’almost 2 years ago
Sticking to the Plan: Undue Burden Created by Protocol DeviationsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
5